FindTrial
Sign In

Medicated Dhoomapana in Excessive Oral Secretion

Chemical Analysis and Field Study of Prayogika Dhoomapana in Shleshma Praseka

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/047843
Enrollment
100
Registered
2022-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Apparently healthy individuals 2.Persons having complaint of Shleshma Praseka 3.Persons willing to give written informed consent

Exclusion criteria

Exclusion criteria: Persons with a history of Acute & Chronic Diseases Persons who are on any Medications Persons having addiction of Smoking & Tobacco chewing Persons allergic to Dhooma During Menstruation, Pregnancy & Lactation

Design outcomes

Primary

MeasureTime frame
Reduction in the Shleshma PrasekaTimepoint: After 1 month—

Secondary

MeasureTime frame
Any other health benefits & side effects assessed by self-made questionnaireTimepoint: After 4 weeks—

Countries

India

Contacts

Public ContactDr Durgawati Devi

National Institute of Ayurveda

dr.somu.the.moon@gmail.com9036199959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026